Compare GE HealthCare Technologies Inc. Common Stock (GEHC) vs Tapestry, Inc. (TPR) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
GE HealthCare Technologies Inc. Common Stock vs Tapestry, Inc. — how do they compare? GE HealthCare Technologies Inc. Common Stock trades at $68.6 (market cap $30.93B), while Tapestry, Inc. trades at $115.67 (market cap $22.83B). The key difference: GE HealthCare Technologies Inc. Common Stock is the larger of the two by market cap, and Tapestry, Inc. pays the higher dividend (1.61%). Which is the better fit depends on your goals.
| GEHC | TPR | |
|---|---|---|
Market Cap | $30.93B | $22.83B |
Volume | 5,033,451 | 1,359,849 |
Sector | Health | Consumer Cyclical |
52-Week High | $88.16 | $164.78 |
52-Week Low | $59.48 | $98.81 |
Enterprise Value | $39.39B | $25.63B |
Dividend Yield | 0.23% | 1.61% |
Typical Hold Time | — | 70 Days |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
GE HealthCare (GEHC) trades at $68.79, up 1.55% today, with a neutral technical signal. The company reported mixed quarterly earnings, beating in Q2 2026 but missing in Q1, and is set to announce Q3 results on October 28, 2026. Recent developments include a $945 million acquisition of SOFIE Biosciences to expand its PET radiopharmaceutical footprint, alongside ongoing securities fraud investigations noted in recent news.
The outlook is cautiously optimistic, supported by a strong analyst consensus with a $79.64 price target and no sell ratings. Key opportunities include growth from strategic acquisitions and AI innovations, while risks involve legal investigations, integration challenges from the SOFIE deal, and potential margin pressures from increased investing cash outflows in 2026.
TPR trades at $115.23, down 1.7% today, with neutral technical signals and strong analyst support. The stock shows robust profitability with 77.82% gross margins and has beaten earnings estimates for three consecutive quarters. Recent developments include expansion into Google's AI shopping ecosystem and accelerating international growth in China and Europe. The company maintains a solid balance sheet with $1.12 billion in cash and manageable debt levels.
TPR presents a compelling investment case with 73% analyst buy ratings and a $174.64 consensus price target representing 52% upside. Strong brand momentum and margin expansion potential are offset by tariff risks and Kate Spade execution challenges. The stock trades at reasonable valuations with a 15.85 P/E ratio, though recent net income decline from $816M to $183M warrants monitoring.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
About GE HealthCare Technologies Inc. Common Stock
GE HealthCare Technologies Inc. is a medical technology company, spun off from General Electric in 2023, that develops imaging systems, ultrasound devices, patient monitoring equipment, and diagnostic imaging agents. Its product lines include CT, MRI, and mammography systems alongside anesthesia delivery and maternal-infant care solutions.
Read more on GEHC →About Tapestry, Inc.
Coach, Kate Spade, and Stuart Weitzman are the fashion and accessory brands that comprise Tapestry. The firm's products are sold through about 1,400 company-operated stores, wholesale channels, and e-commerce in North America (67% of fiscal 2022 sales), Europe, Asia (28% of fiscal 2022 sales), and elsewhere. Coach (74% of fiscal 2022 sales) is best known for affordable luxury leather products. Kate Spade (22% of fiscal 2022 sales) is known for colorful patterns and graphics. Women's handbags and accessories produced 69% of Tapestry's sales in fiscal 2022. Stuart Weitzman, Tapestry's smallest brand, generates nearly all its revenue from women's footwear.
Read more on TPR →
